A detailed history of Victory Capital Management Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 38,660 shares of MEDP stock, worth $12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,660
Previous 68,486 43.55%
Holding current value
$12 Million
Previous $28.2 Million 54.29%
% of portfolio
0.01%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$320.58 - $457.29 $9.56 Million - $13.6 Million
-29,826 Reduced 43.55%
38,660 $12.9 Million
Q2 2024

Aug 05, 2024

BUY
$372.0 - $424.34 $3.84 Million - $4.38 Million
10,320 Added 17.74%
68,486 $28.2 Million
Q1 2024

May 03, 2024

SELL
$284.87 - $413.31 $2.99 Million - $4.34 Million
-10,491 Reduced 15.28%
58,166 $23.5 Million
Q4 2023

Feb 05, 2024

BUY
$227.52 - $312.68 $2.76 Million - $3.79 Million
12,127 Added 21.45%
68,657 $21 Million
Q3 2023

Nov 06, 2023

SELL
$233.98 - $281.67 $1.06 Million - $1.27 Million
-4,526 Reduced 7.41%
56,530 $13.7 Million
Q2 2023

Jul 27, 2023

SELL
$187.26 - $240.17 $52,058 - $66,767
-278 Reduced 0.45%
61,056 $14.7 Million
Q1 2023

May 02, 2023

SELL
$174.31 - $239.52 $2.65 Million - $3.64 Million
-15,197 Reduced 19.86%
61,334 $11.5 Million
Q4 2022

Feb 10, 2023

SELL
$153.06 - $226.57 $4.89 Million - $7.23 Million
-31,929 Reduced 29.44%
76,531 $16.3 Million
Q4 2022

Feb 09, 2023

BUY
$153.06 - $226.57 $3.75 Million - $5.55 Million
24,489 Added 29.16%
108,460 $23 Million
Q3 2022

Nov 02, 2022

BUY
$145.13 - $182.49 $5.2 Million - $6.54 Million
35,862 Added 74.54%
83,971 $13.2 Million
Q2 2022

Aug 01, 2022

BUY
$130.2 - $168.03 $83,197 - $107,371
639 Added 1.35%
48,109 $7.2 Million
Q1 2022

May 04, 2022

BUY
$138.87 - $214.31 $231,912 - $357,897
1,670 Added 3.65%
47,470 $7.31 Million
Q4 2021

Feb 07, 2022

SELL
$182.74 - $227.9 $2.05 Million - $2.55 Million
-11,196 Reduced 19.64%
45,800 $9.97 Million
Q3 2021

Nov 02, 2021

SELL
$170.18 - $198.21 $66,370 - $77,301
-390 Reduced 0.68%
56,996 $10.8 Million
Q2 2021

Aug 03, 2021

SELL
$158.62 - $194.3 $1.94 Million - $2.38 Million
-12,250 Reduced 17.59%
57,386 $10.1 Million
Q1 2021

May 04, 2021

BUY
$132.02 - $168.26 $3.83 Million - $4.88 Million
28,976 Added 71.26%
69,636 $11.4 Million
Q4 2020

Feb 01, 2021

BUY
$109.38 - $149.19 $38,829 - $52,962
355 Added 0.88%
40,660 $5.66 Million
Q3 2020

Nov 09, 2020

SELL
$92.95 - $130.61 $63,856 - $89,729
-687 Reduced 1.68%
40,305 $4.5 Million
Q2 2020

Aug 07, 2020

BUY
$68.08 - $95.68 $781,354 - $1.1 Million
11,477 Added 38.89%
40,992 $3.81 Million
Q1 2020

May 04, 2020

BUY
$61.71 - $101.95 $916,948 - $1.51 Million
14,859 Added 101.39%
29,515 $2.17 Million
Q4 2019

Feb 06, 2020

SELL
$70.08 - $84.64 $8,689 - $10,495
-124 Reduced 0.84%
14,656 $1.23 Million
Q4 2019

Feb 04, 2020

BUY
$70.08 - $84.64 $208,417 - $251,719
2,974 Added 25.19%
14,780 $1.26 Million
Q3 2019

Nov 12, 2019

BUY
$62.38 - $85.89 $655,489 - $902,532
10,508 Added 809.55%
11,806 $992,000
Q2 2019

Aug 15, 2019

SELL
$53.64 - $65.42 $120,958 - $147,522
-2,255 Reduced 63.47%
1,298 $85,000
Q1 2019

May 03, 2019

SELL
$49.38 - $70.58 $46,762 - $66,839
-947 Reduced 21.04%
3,553 $210,000
Q4 2018

Feb 05, 2019

BUY
$46.97 - $63.98 $8,125 - $11,068
173 Added 4.0%
4,500 $238,000
Q3 2018

Nov 01, 2018

SELL
$43.25 - $63.74 $119,543 - $176,177
-2,764 Reduced 38.98%
4,327 $259,000
Q2 2018

Aug 02, 2018

BUY
$34.03 - $45.46 $33,145 - $44,278
974 Added 15.92%
7,091 $305,000
Q1 2018

May 04, 2018

BUY
$32.03 - $39.05 $195,927 - $238,868
6,117 New
6,117 $214,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.